Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Papua New Guinea.
Press releases published on September 3, 2025
Total Warehouse Reports 10% B2B Growth Following AGV Launch
GlobeNewswire
·
September 3, 2025
ANAHEIM, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Total Warehouse today announced a 10% increase in B2B customer acquisitions following the launch of its partnership with automation leader Dematic. The company’s direct import of Dematic’s Automated Guided …
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
GlobeNewswire
·
September 3, 2025
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference …
Descartes Announces Fiscal 2026 Second Quarter Financial Results
GlobeNewswire
·
September 3, 2025
Record Revenues and Income from Operations WATERLOO, Ontario and ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2026 second quarter (Q2FY26). All financial …
Wyoming Horse Racing Selects Quick Custom Intelligence Enterprise Platform
GlobeNewswire
·
September 3, 2025
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) and Wyoming Horse Racing are thrilled to announce their strategic partnership that is set to transform the gaming and hospitality landscape in the Wyoming market. This dynamic …
Altai Announces Shareholder Approval of Special Resolution
GlobeNewswire
·
September 3, 2025
TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced that at today’s special meeting (the “Meeting”) of shareholders of the Company (the “Shareholders”), the Shareholders approved, with …
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 3, 2025
HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being …
No Limits and Olivier Clovis Scaling Business Form Strategic Partnership to Support Entrepreneur Growth Across Europe
GlobeNewswire
·
September 3, 2025
Geneva, Switzerland , Sept. 03, 2025 (GLOBE NEWSWIRE) -- No Limits, the all-in-one ecosystem dedicated to entrepreneurial optimization, today announced a strategic partnership with Olivier Clovis Scaling Business, a Swiss company specializing in digital …
Artelo Biosciences Announces Proposed Underwritten Public Offering
GlobeNewswire
·
September 3, 2025
SOLANA BEACH, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
dLocal Announces Launch of Secondary Offering
GlobeNewswire
·
September 3, 2025
MONTEVIDEO, Uruguay, Sept. 03, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal” or the “Company”), (NASDAQ:DLO) a technology-first payments platform, today announced the commencement of an underwritten registered secondary offering of 15,000,000 Class A …
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 3, 2025
Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage …
DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment
GlobeNewswire
·
September 3, 2025
Châtillon, France, le 3 septembre (22:30 CEST) 2025 DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP : 23306J309), une …
New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression
GlobeNewswire
·
September 3, 2025
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies1 that …
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd
GlobeNewswire
·
September 3, 2025
– Expands Avadel’s pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter 2025 …
374Water Announces Open-Market Purchases of Company Stock by Board Members and Senior Management
GlobeNewswire
·
September 3, 2025
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology and services for the municipal, federal, and industrial markets, today announced recent …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
GlobeNewswire
·
September 3, 2025
WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of …
Rail Vision Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
GlobeNewswire
·
September 3, 2025
Ra’anana, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced that it has received a …
Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC
GlobeNewswire
·
September 3, 2025
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or "Company"), a clinical-stage biotechnology company, announced that it has signed an Exclusive License Agreement with Novatim Immune Therapeutics (Zhejiang) CO., LTD. , (“ …
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
GlobeNewswire
·
September 3, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Longeveron® Announces Key Leadership Updates
GlobeNewswire
·
September 3, 2025
Than Powell, Chief Business Officer and head of business development, appointed Interim CEO Dr. Joshua Hare, co-founder and chief science officer, appointed Executive Chairman of the Board of Directors Wa’el Hashad to step down as CEO and Board member …